These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10534334

  • 1. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection.
    Sebagh M, Debette M, Samuel D, Emile JF, Falissard B, Cailliez V, Shouval D, Bismuth H, Reynès M.
    Hepatology; 1999 Nov; 30(5):1144-50. PubMed ID: 10534334
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.
    Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E, Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D.
    Liver Transpl; 2011 Jul; 17(7):798-808. PubMed ID: 21351239
    [Abstract] [Full Text] [Related]

  • 4. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y, Chisuwa H, Mita A, Ikegami T, Hashikura Y, Terada M, Nakayama J, Kawasaki S.
    Transplantation; 2003 Mar 15; 75(5):727-30. PubMed ID: 12640317
    [Abstract] [Full Text] [Related]

  • 5. [Veno-occlusive disease after liver transplantation. Association of acute cellular rejection and toxicity of azathioprine].
    Mion F, Cloix P, Boillot O, Gille D, Bouvier R, Paliard P, Berger F.
    Gastroenterol Clin Biol; 1993 Mar 15; 17(11):863-7. PubMed ID: 8143956
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience.
    Górnicka B, Ziarkiewicz-Wróblewska B, Bogdańska M, Ołdakowska-Jedynak U, Wróblewski T, Morton M, Ziółkowski J, Paczek L, Krawczyk M, Wasiutyński A.
    Transplant Proc; 2006 Mar 15; 38(1):221-5. PubMed ID: 16504708
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
    Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C.
    Bone Marrow Transplant; 1991 Jun 15; 7(6):467-74. PubMed ID: 1908340
    [Abstract] [Full Text] [Related]

  • 12. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
    Moscardó F, Sanz GF, de La Rubia J, Jiménez C, Saavedra S, Regadera A, Andreu R, García I, Plumé G, Martínez J, Martín G, Jarque I, Sanz MA.
    Bone Marrow Transplant; 2001 May 15; 27(9):983-8. PubMed ID: 11436110
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A, Kobayashi R, Yoshida M, Kobayashi K, Matsuo K, Kitajima I, Maruyama I.
    Bone Marrow Transplant; 2001 Jun 15; 27(11):1173-80. PubMed ID: 11551028
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens.
    Bilezikçi B, Demirhan B, Kocbiyik A, Arat Z, Haberal M.
    Transplant Proc; 2008 Jun 15; 40(1):248-50. PubMed ID: 18261599
    [Abstract] [Full Text] [Related]

  • 17. Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode.
    Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE.
    Liver Transpl; 2004 Mar 15; 10(3):369-73. PubMed ID: 15004763
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
    Kami M, Mori S, Tanikawa S, Akiyama H, Onozawa Y, Tanaka T, Okamoto R, Maeda Y, Sasaki T, Kaku H, Matsuura Y, Hiruma K, Sakamaki H.
    Bone Marrow Transplant; 1997 Sep 15; 20(5):397-402. PubMed ID: 9339756
    [Abstract] [Full Text] [Related]

  • 20. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
    Horn B, Reiss U, Matthay K, McMillan A, Cowan M.
    Bone Marrow Transplant; 2002 Mar 15; 29(5):409-15. PubMed ID: 11919731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.